NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activationPeng Zhang, Yongwen Luo|Cell Death and Disease|2023Cited by 59
Tyrosine receptor kinase B silencing inhibits anoikis-resistance and improves anticancer efficiency of sorafenib in human renal cancer cellsPeng Zhang, Yifei Xing|International Journal of Oncology|2016Cited by 32